Topline
Barclays CEO C.S. Venkatakrishnan, who took over as chief executive of the British banking giant a year ago, will begin treatment for cancer but does not plan to step down from his role, the company said.
Barclays CEO C.S. Venkatakrishnan arrives at the Treasury office in central London on September 7, ... [+]
Key Facts
Barclays said in a regulatory filing Monday that 56-year-old Venkatakrishnan had been diagnosed with non-Hodgkin’s lymphoma, a form of cancer that begins in the lymphatic system.
In a note to Barclays employees, Venkatakrishnan said the disease had been detected early and that the cancer remains localized, with doctors saying it is likely curable with treatment expected to last 12 to 16 weeks.
Venkatakrishnan will continue to run the company largely as normal, he said in the note, though he will have to work from home and will not travel.
Barclays did not immediately return Forbes' request for comment.
Key Background
Venkatakrishnan became Barclays CEO in November 2021 after former chief executive Jes Staley stepped down over his ties to late disgraced financier Jeffrey Epstein. Staley led the company since 2015. Before Venkatakrishnan took over, he had worked as the firm’s chief risk officer, head of global markets and co-president of BBPLC, Barclays’ largest entity.
Big Number
$30.2 billion. That’s how much in revenue Barclays reported during fiscal year 2022, up from $27.9 billion the previous year.
Tangent
Venkatakrishnan isn’t the first boss of a major bank to receive cancer treatment while working. In 2014, JPMorgan Chase CEO Jamie Dimon underwent treatment for throat cancer and announced he was cancer-free the same year.
Further Reading
Barclays Chief Executive Jes Staley Steps Down Over Epstein Investigation (Forbes)
